BDBM181732 US9676728, 5 b (-)-2-(2,2,2-Trifluoro-1-(2-methoxy-4,6-dimethylphenyl)-1-(methylamino)ethyl)-1H-benzo[d]imidazole-5-carbonitrile

SMILES CNC(c1nc2cc(ccc2[nH]1)C#N)(c1c(C)cc(C)cc1OC)C(F)(F)F

InChI Key InChIKey=UCKKPCZNZHKBKC-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 181732   

TargetComplement factor B(Human)
Novartis

US Patent
LigandPNGBDBM181732(US9676728, 5 b (-)-2-(2,2,2-Trifluoro-1-(2-methoxy...)
Affinity DataIC50: 23nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2018
Entry Details
Go to US Patent

TargetComplement factor B(Human)
Novartis

US Patent
LigandPNGBDBM181732(US9676728, 5 b (-)-2-(2,2,2-Trifluoro-1-(2-methoxy...)
Affinity DataIC50: 1.90E+3nMpH: 7.4 T: 2°CAssay Description:CVF-Bb complex prepared from purified cobra venom factor (1 μM), recombinant human complement factor B (expressed in drosophila cells and purifi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2018
Entry Details
Go to US Patent